PD-L1, a Potential Immunomodulator Linking Immunology and Orthodontically Induced Inflammatory Root Resorption (OIIRR): Friend or Foe?

Int J Mol Sci. 2022 Sep 27;23(19):11405. doi: 10.3390/ijms231911405.

Abstract

Orthodontically induced inflammatory root resorption (OIIRR) is considered an undesired and inevitable complication induced by orthodontic forces. This inflammatory mechanism is regulated by immune cells that precede orthodontic tooth movement (OTM) and can influence the severity of OIIRR. The process of OIIRR is based on an immune response. On some occasions, the immune system attacks the dentition by inflammatory processes during orthodontic treatment. Studies on the involvement of the PD-1/PD-L1 immune checkpoint have demonstrated its role in evading immune responses, aiming to identify possible novel therapeutic approaches for periodontitis. In the field of orthodontics, the important question arises of whether PD-L1 has a role in the development of OIIRR to amplify the amount of resorption. We hypothesize that blocking of the PD-L1 immune checkpoint could be a suitable procedure to reduce the process of OIIRR during orthodontic tooth movement. This review attempts to shed light on the regulation of immune mechanisms and inflammatory responses that could influence the pathogenesis of OIIRR and to acquire knowledge about the role of PD-L1 in the immunomodulation involved in OIIRR. Possible clinical outcomes will be discussed in relation to PD-L1 expression and immunologic changes throughout the resorption process.

Keywords: OIIRR; PD-L1; cementoblasts; cementum; immunology; immunorthodontics; orthodontic force; orthodontic tooth movement.

Publication types

  • Review

MeSH terms

  • B7-H1 Antigen* / immunology
  • Humans
  • Immunologic Factors
  • Programmed Cell Death 1 Receptor
  • Root Resorption* / etiology
  • Root Resorption* / immunology
  • Tooth Movement Techniques* / adverse effects
  • Tooth Movement Techniques* / methods

Substances

  • B7-H1 Antigen
  • CD274 protein, human
  • Immunologic Factors
  • Programmed Cell Death 1 Receptor

Grants and funding

This research received no external funding.